NA - Patient stratification factor · neurodegeneration · -
Composite 0.515
Price $0.51
Evidence For 0
Evidence Against 0
In advanced neurodegeneration, p-tau217 may no longer reflect ongoing pathology due to loss of viable neurons capable of producing tau. Patients with severe atrophy may show spurious p-tau217 normalization due to floor effects, making it unreliable as a stopping rule. However, no threshold defines 'severe' neurodegeneration for this purpose, and the relationship between structural atrophy and neuronal p-tau217 production capacity is not established. The hypothesis identifies an important confoun
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.55
Evidence
0.45
Novelty
0.58
Feasibility
0.48
Impact
0.52
Druggability
0.30
Safety
0.62
Competition
0.70
Data
0.50
Reproducible
0.45
KG Connect
0.50
Score Breakdown
Dimension
CSF p-tau217 Normalization Req
Mechanistic
0.550
Evidence
0.450
Novelty
0.580
Feasibility
0.480
Impact
0.520
Druggability
0.300
Safety
0.620
Competition
0.700
Data
0.500
Reproducible
0.450
KG Connect
0.500
Evidence
CSF p-tau217 Normalization Requires Intact Synaptic Function